IOVA FY 2022 Earnings — Iovance Biotherapeutics, Inc. Revenue & Financial Results | Market Cap Arena

IOVAIovance Biotherapeutics, Inc.

$2B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$399M

Net Income

-$396M

EPS (Diluted)

$-2.49

Cash Flow

Operating Cash Flow

-$293M

Free Cash Flow

-$313M

Stock-Based Comp.

$84M

Balance Sheet

Total Assets

$664M

Total Liabilities

$164M

Stockholders' Equity

$500M

Cash & Equivalents

$232M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$399M	-$343M	-16.4%
Net Income	-$396M	-$342M	-15.7%